The design of a new truncated and engineered alpha1-antitrypsin based on theoretical studies: an antiprotease therapeutics for pulmonary diseases
Open Access
- 24 May 2013
- journal article
- research article
- Published by Springer Nature in Theoretical Biology and Medical Modelling
- Vol. 10 (1) , 36
Abstract
Alpha 1- antitrypsin (α1AT) a 54 kDa glycoprotein is a protease inhibitor. In the absence of α1AT, elastase released by lung macrophages, was not inhibited and lead to elastin breakdown and pulmonary problems such as emphysema or COPD. α1AT has three site of N-glycosylation and a characteristic reactive central loop (RCL). As small-scale medicines are preferred for pulmonary drug delivery, in this study α1ATs (1, 2, 3, 4 and 5) were engineered and shortened from the N-terminal region. In order to investigate the effect of different mutations and the deletion of 46 amino acids theoretical studies were performed. Homology modeling was performed to generate the 3D structure of α1ATs. The 10 ns Molecular Dynamic (MD) simulations were carried out to refine the models. Results from MD and protein docking showed that α1AT2 has the highest binding affinity for neutrophil elastase, provided the basis for the experimental phase in which sequences from the five α1AT constructs were inserted into the expression vector pGAPZα and expressed in the yeast Pichia pastoris. Although, the α1AT2 construct has the highest inhibitory activity even more that the native construct (α1AT5), results indicated the presence of protease inhibitory function of all the proteins' construct against elastase.Keywords
This publication has 29 references indexed in Scilit:
- Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysemaOrphanet Journal of Rare Diseases, 2011
- Low plasma levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNFα), and vascular endothelial growth factor (VEGF) in patients with alpha1-antitrypsin deficiency-related fibromyalgiaClinical Rheumatology, 2009
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular SimulationJournal of Chemical Theory and Computation, 2008
- I-TASSER server for protein 3D structure predictionBMC Bioinformatics, 2008
- Recombinant human alpha-1 proteinase inhibitor: towards therapeutic useAmino Acids, 2006
- Pathogenic α1-Antitrypsin Polymers Are Formed by Reactive Loop-β-Sheet A LinkageJournal of Biological Chemistry, 2000
- Oxidation of either methionine super351 or methionine super358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activityJournal of Biological Chemistry, 2000
- Effective treatment with α1-protease inhibitor of chronic cutaneous vasculitis associated with α1-antitrypsin deficiencyJournal of the American Academy of Dermatology, 1995
- GROMACS: A message-passing parallel molecular dynamics implementationComputer Physics Communications, 1995
- Effects of mutations in the hinge region of serpinsBiochemistry, 1993